top of page

May 2018 // Science

Updated: Nov 6, 2020

Publication of a scientific article describing the pharmacology of WOBE437 (first generation SERI) in a mouse model of pain and chronic inflammation. Reynoso-Moreno I et al., Front Mol Neurosci. 2018 May 28;11:180. Full text: https://www.frontiersin.org/articles/10.3389/fnmol.2018.00180/full

Recent Posts

See All

July 2023 // Communication

Synendos Therapeutics AG announces that co-founder and Scientific Advisor Board member, Professor Jürg Gertsch, presented groundbreaking new findings on an endocannabinoid transporter at the 10th Gord

June 2022 // Communication

In a last newsletter edition from NCCR Transcure, we can look behind the scenes of our technology transfer success story.

March 2021 // Science

We are excited to share a scientific publication about the beneficial effect of the prototype SERI WOBE437 in a clinically relevant mouse model of Multiple Sclerosis and transient spasticity. The arti

Comments


bottom of page